Barclays Maintains Underweight on NOV, Lowers Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst David Anderson has maintained an Underweight rating on NOV and lowered the price target from $20 to $17.
October 16, 2024 | 7:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays has maintained an Underweight rating on NOV and reduced the price target from $20 to $17, indicating a bearish outlook.
The Underweight rating suggests that Barclays expects NOV to underperform relative to the market. The lowered price target from $20 to $17 indicates a negative outlook on the stock's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100